News & Videos - ALCON N

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six months ended June 30, 2023. For the second quarter of 2023, sales were $2.4 billion, an increase of 9% on a reported basis and 12% on a constant currency basis (1) , as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.34 and core diluted earnings per share (2) of $0.69 in the second quarter of 2023. David J. Endicott, Alcon's Chief Executive...

Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six months ended June 30, 2023. For the second quarter of 2023, sales were $2.4 billion, an increase of 9% on a reported basis and 12% on a constant currency basis (1) , as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.34 and core diluted earnings per share (2) of $0.69 in the second quarter of 2023. David J. Endicott, Alcon's...

Regulatory News: Working together to make a brilliant impact in the communities where they live and work, thousands of Alcon associates from 57 locations around the world are participating in Alcon in Alcon (AiA), a company-wide volunteering initiative. AiA expands Alcon’s year-round focus on increasing access to quality eye care and is an element of Alcon’s overall social impact and sustainability strategy which focuses on three pillars: Brilliant Lives, Brilliant Innovation and Brilliant...

Working together to make a brilliant impact in the communities where they live and work, thousands of Alcon associates from 57 locations around the world are participating in Alcon in Alcon (AiA), a company-wide volunteering initiative. AiA expands Alcon’s year-round focus on increasing access to quality eye care and is an element of Alcon’s overall social impact and sustainability strategy which focuses on three pillars: Brilliant Lives, Brilliant Innovation and Brilliant Planet . This is...

Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2023. For the first quarter of 2023, sales were $2.3 billion, an increase of 7% on a reported basis and 11% on a constant currency basis (1) , as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.35 and core diluted earnings per share (2) of $0.70 in the first quarter of 2023. David J. Endicott, Alcon's Chief...

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2023. For the first quarter of 2023, sales were $2.3 billion, an increase of 7% on a reported basis and 11% on a constant currency basis (1) , as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.35 and core diluted earnings per share (2) of $0.70 in the first quarter of 2023. David J. Endicott, Alcon's Chief Executive Officer,...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting taking place in San Diego, CA (May 5-8). The investigator-initiated study ** led by J. Morgan Micheletti, M.D., demonstrated that Clareon ® and Eyhance * monofocal IOLs provide similar range of vision, including distance and intermediate visual acuity. 1 “The...

Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2023 Annual General Meeting (AGM). A total of 321,168,907 shares with a nominal value of CHF 0.04 each, representing an aggregate nominal value of CHF 12,846,756.28, were represented at today's AGM. Shareholders re-elected F. Michael Ball as member and Chair of the Board of Directors, and the other members of the Board who all...

Regulatory News: Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2023 Annual General Meeting (AGM). A total of 321,168,907 shares with a nominal value of CHF 0.04 each, representing an aggregate nominal value of CHF 12,846,756.28, were represented at today's AGM. Shareholders re-elected F. Michael Ball as member and Chair of the Board of Directors, and the other members of the...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will once again have the largest surgical ophthalmic presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2023 Annual Meeting, taking place May 5-8 in San Diego. The company is proud to have the benefits of its innovations featured in more studies than ever in its history. 1 Alcon will showcase product updates that drive efficiencies for ophthalmologists and staff, and host...

Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 5, 2023. Alcon is pleased to welcome shareholders to its first in-person AGM since becoming an independent, standalone company in April 2019. The company looks forward to hearing directly from its shareholders at this open format meeting. The agenda for this 2023 AGM consists of the regular items as required by law, as well as the proposal to amend Alcon’s Articles of...

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 5, 2023. Alcon is pleased to welcome shareholders to its first in-person AGM since becoming an independent, standalone company in April 2019. The company looks forward to hearing directly from its shareholders at this open format meeting. The agenda for this 2023 AGM consists of the regular items as required by law, as well as the proposal to amend Alcon’s Articles of Incorporation, in line...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2 nd Annual Anthem Awards. Launched in 2021 by The Webby Awards, The Anthem Award winners are selected by the International Academy of Digital Arts and Sciences. The interactive compliance experience was developed by Alcon’s Legal and Compliance team along with...

Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2023 Capital Markets Day on March 30, 2023 beginning at 8:00 a.m. CT. A live webcast of the event will be available at https://investor.alcon.com/news-and-events/events-and-presentations/default.aspx . About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and...

Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2023 Capital Markets Day on March 30, 2023 beginning at 8:00 a.m. CT. A live webcast of the event will be available at https://investor.alcon.com/news-and-events/events-and-presentations/default.aspx . About Alcon Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives....

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will unveil its latest innovations and expansive suite of vision care products at the SECO International meeting in Atlanta, Georgia. Alcon will debut TOTAL30 ® for Astigmatism, the first and only reusable Water Gradient toric lens on the market, 1 now available to Eye Care Professionals (ECPs) across the U.S. In addition to showcasing its latest innovations, Alcon will present its newest clinical...

Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve months ended December 31, 2022. For the fourth quarter of 2022, sales were $2.2 billion, an increase of 1% on a reported basis and 7% on a constant currency basis (1) , as compared to the same quarter of the previous year. Alcon reported a loss per share of $0.20 and core diluted earnings per share (2) of $0.42 in the fourth quarter of 2022. David J. Endicott, Alcon's...

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve months ended December 31, 2022. For the fourth quarter of 2022, sales were $2.2 billion, an increase of 1% on a reported basis and 7% on a constant currency basis (1) , as compared to the same quarter of the previous year. Alcon reported a loss per share of $0.20 and core diluted earnings per share (2) of $0.42 in the fourth quarter of 2022. David J. Endicott, Alcon's Chief Executive...

Alcon Inc. ("Alcon") (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into a settlement agreement with J&J Surgical Vision, Inc. to resolve their pending legal proceedings relating to femtosecond laser assisted cataract surgery devices, including Alcon’s LenSx ® device, which Alcon acquired as part of its purchase of LenSx Lasers, Inc. in 2010. As part of the resolution of this matter, the parties have exchanged...

Regulatory News: Alcon Inc. ("Alcon") (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into a settlement agreement with J&J Surgical Vision, Inc. to resolve their pending legal proceedings relating to femtosecond laser assisted cataract surgery devices, including Alcon’s LenSx ® device, which Alcon acquired as part of its purchase of LenSx Lasers, Inc. in 2010. As part of the resolution of this matter, the parties...